The evolving cancer stem cell paradigm: implications in veterinary oncology

Area of Science:

• Oncology
• Cell Biology
• Cancer Research

Background:

• The cancer stem cell model posits distinct cancer cell subpopulations with high tumor-initiating and self-renewal capabilities.
• These cells are intrinsically resistant to conventional therapies and drive tumor growth, metastasis, and relapse.
• Tumors have been conceptualized as hierarchical tissues with cancer stem cells at the apex.

Purpose of the Study:

• To review recent advancements in cancer stem cell (CSC) research.
• To focus on key areas including tumor heterogeneity, cellular plasticity, and CSC reprogramming.
• To discuss the implications of these developments for the existing cancer stem cell model.

Main Methods:

• Literature review of recent developments in cancer stem cell research.
• Analysis of studies focusing on tumor heterogeneity and cellular plasticity.
• Examination of research on cancer stem cell reprogramming.

Main Results:

• Tumor heterogeneity and cellular plasticity challenge the strict hierarchical CSC model.
• Cancer stem cell reprogramming emerges as a significant factor influencing tumor behavior.
• Evidence suggests a more dynamic and less rigid structure within tumors than previously assumed.

Conclusions:

• Recent findings necessitate a re-evaluation and potential refinement of the cancer stem cell model.
• Understanding tumor heterogeneity, plasticity, and reprogramming is crucial for developing novel cancer therapies.
• The dynamic nature of cancer cells offers new therapeutic targets beyond traditional cancer stem cells.